Feature | May 20, 2014

FDA Gathers Information on How to Regulate 3-D Printing of Medical Devices

Workshop will look at technical considerations for printing medical devices on demand

3-d pronting, 3D printing

The University of Arizona is using 3-D printing of pediatric patients chest cavities and organs to confirm if the Syncardia ventricular assist device (VAD) can fit in specific patients.

May 20, 2014 — It is possible to use 3-D printer technology to create some types of customized medical devices on demand, and some research centers are developing technology to print more complex devices like heart valves using biocompatible materials. The Food and Drug Administration (FDA) has recognized the technology now exists to print these types of devices and is gathering information regarding technical assessments that should be considered when it will inevitably begin reviewing these types of future FDA submissions.

The FDA will host a workshop titled “Additive Manufacturing of Medical Devices: An Interactive Discussion on the Technical Considerations of 3-D Printing,” Oct. 8-9, 2014, from 8 a.m. to 5 p.m. in Silver Spring, Md. The purpose of this workshop is to provide a forum for FDA, medical device manufactures, additive manufacturing companies and academia to discuss technical challenges and solutions of 3-D printing. 

Additive manufacturing, also known as 3-D printing, is a fast- growing manufacturing technique that builds devices from computerized blueprints or models, by layering material only where it is needed as if building with interlocking bricks. Traditional methods of manufacturing remove material from larger pieces by cutting, drilling, and carving to create a final part. Through additive manufacturing designers can alter products quickly for rapid prototype iteration or produce small batches of multiple product designs in each batch. The 3- D computer models used to build each part can be created using traditional computer-aided design techniques or they can be made directly from 3-D image sources, such as computed tomography (CT) scans or magnetic resonance imaging (MRI). Designers can also use a combination of techniques. Consequently, the FDA said 3-D printers can create truly anatomically matched devices or surgical guides by utilizing a patient's own medical imaging. 
 
Additive manufacturing is just beginning to enter mainstream use in medical devices. The FDA said this technology unlocks new avenues for creativity and innovation for medical device designers. For example, the FDA said it can facilitate the production of devices with intricate structures that were previously impractical or impossible. Current industry applications include using it as an alternative device production method for traditional components or as a primary method to create patient-matched devices. As the technology matures, additional capabilities may be incorporated into medical devices. 
 
FDA said it already has begun to receive submissions using additive manufacturing for both traditional and patient-matched devices, and it sees many more on the horizon. Industry forecasts project significant growth of additive manufacturing in both traditional and innovative environments by 2025.   
 
Additive manufacturing may or may not present new questions depending on its use. However, the FDA said it realizes there are technical challenges associated with the process from design to final product that need to be properly addressed in all cases to ensure patient safety and to promote innovation in a fast-moving field. Process verification and validation are especially important when devices are produced individually or in very small batches. 
 
By discussing and addressing these technical challenges through an open forum, FDA would like to foster innovation with a transparent process and shared expectations for stakeholders. Participants in the October workshop will include researchers, scientists and engineers involved with the research and development of products using additive manufacturing as one or more steps of the manufacturing process. The intent is to address scientific and technical challenges posed by additive manufacturing process, but not address specific printing technologies or medical device types. The latter will still be covered by their respective standards and guidance documents. Ideas generated during this workshop may facilitate development of new draft guidance and/or standards for additive manufacturing of medical devices. 
 
The FDA said it will include discussions on several topics, including preprinting considerations, including material chemistry, physical properties, recyclability, part reproducibility and process validation. Printing considerations will include printing process characterization, software used in the process, post-processing steps such as curing, and  additional machining. Post-printing considerations will include cleaning/excess material removal, effect of complexity on sterilization and biocompatibility, final device mechanics, design envelope and verification. 
 
For more information: http://www.gpo.gov/fdsys/pkg/FR-2014-05-19/html/2014-11513.htm?source=govdelivery&utm_medium=email&utm_source=govdelivery
 
 

Related Content

Montreal Heart Institute Performs First Robotic Mitral Valve Surgery
News | Robotic Systems| September 22, 2017
The Montreal Heart Institute (MHI) announced the acquisition of the da Vinci Xi, a new-generation surgical robot, and...
Tryton Side Branch Stent Recognized With Premier Technology Breakthrough Award
News | Stents Bifurcation| September 21, 2017
September 21, 2017 — Cardinal Health and Tryton Medical Inc.
DISRUPT BTK Study Shows Positive Results With Lithoplasty in Calcified Lesions Below the Knee
News | Peripheral Artery Disease (PAD)| September 20, 2017
Shockwave Medical reported positive results from the DISRUPT BTK Study, which were presented at the annual...
Gecko Biomedical Receives CE Mark Approval for Setalum Sealant
News | Cardiovascular Surgery| September 19, 2017
Gecko Biomedical announced it has received CE Mark approval for its Setalum Sealant, allowing the company to market its...
Corindus Announces First Patient Enrolled in PRECISION GRX Registry
News | Robotic Systems| September 18, 2017
September 18, 2017 — Corindus Vascular Robotics Inc.
Two-Year ILLUMENATE Trial Data Demonstrate Efficacy of Stellarex Drug-Coated Balloon
News | Drug-Eluting Balloons| September 18, 2017
Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU RCT) demonstrating...
Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices| September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Feature | Cath Lab| September 14, 2017
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials
Mississippi Surgical and Vascular Center Uses Toshiba Ultimax-i FPD to Save Patients' Limbs
News | Angiography| September 14, 2017
The southern U.S. sees some of the highest numbers of chronic medical conditions, such as peripheral artery disease...
Overlay Init